Additional Information

Description

Hydralazine HCL Injection is a medication primarily used for the treatment of hypertension (high blood pressure) and heart failure. It works by relaxing blood vessels and increasing the supply of blood and oxygen to the heart while reducing its workload. The medication is administered via injection, making it suitable for rapid onset of action in acute situations.

Each single-dose vial contains a sterile solution with a concentration of 20 mg/mL of hydralazine hydrochloride. This concentration allows for accurate dosing, especially in critical care settings where precise medication delivery is essential. The vials are designed for single use, helping to prevent contamination and ensuring patient safety.

FRESENIUS KABI, a reputable pharmaceutical manufacturer, produces this medication, providing healthcare professionals with a trusted source for their pharmaceutical needs. The packaging of 25 vials per box ensures an ample supply of the medication, suitable for hospitals, clinics, and other healthcare facilities where hydralazine is routinely used for patient care.